Argenica Therapeutics Ltd has released a press release.
WHO Confirms Xaranetide as INN for ARG-007
Earlier from Argenica Therapeutics
- IND Application Advanced With Successful Completion of Assay
- Clinical Advisory Committee Established to Advance Phase 2b
- Presentations at European Stroke Organisation Conference
- Argenica Receives $3.97m R&D Tax Incentive Cash Rebate